Litecoin (LTC) and Injective (INJ) Both Face Rejection Worried Traders Turn to Pullix (PLX) as It Introduces Liquidity Provision

/Pullix/ – Litecoin (LTC) has showcased a decrease in its price performance, which has left many worried about its future price prospects, yet the on-chart data does showcase an optimistic outlook for the crypto if it manages to break above a key resistance level.

In addition, Injective (INJ) is also getting significant attention from the on-chart data despite consolidating within a given range, where bulls began to lose momentum and dominance over it. Despite this, the Pullix (PLX) presale is dominant and is attracting investor attention at a rapid pace. Today, we will go over the price performance for each crypto to determine how far they can rise.

Litecoin (LTC) Fails to Enter the Bullish Zone – Is a Breakthrough Likely in 2024?

The Litecoin (LTC) price performance indicates that the cryptocurrency has not yet entered the bullish zone. If it breaks down even further, the Litecoin price could be dragged down further. Recently, LTC altcoin broke below the 20, 50, and 200-day EMAs on the chart, indicating that a drop is likely.

However, things can turn in the opposite direction for the Litecoin crypto as well, as its RSI is heading upwards. If buying pressure increases, then LTC has the potential to experience a notable upswing in the near future. According to the Litecoin price prediction, by the end of 2024, it can reach $120.88.

Injective (INJ) Faces Rejection at $50 – Can It Climb During 2024?

Injective (INJ) has been showing signs of weakness, as it has been hovering back and forth within a range during the previous trading sessions. It now needs to break above the $50 price barrier in order to reach new heights, as the Injective price has moved from $33.72 to $41.67 during the past week.

Despite the massive upswing and break above the $40 price range, it retraced back to $33, worrying traders. Yes, the Injective crypto price trend could see a resurgence soon. If it manages to remain above the 50-day and 200-day EMAs, it could result in a positive trend prevailing. According to the Injective price prediction, it can end 2024 at a value of $60.48.

Pullix (PLX) Will Introduce Liquidity Provision and Increased Transparency

Pullix (PLX) will introduce a Web3 marketplace in which a combination of the best CEX and DEX elements will be introduced. Any investor can maintain full control over their assets without any third-party interference.

Through this approach, the platform can establish a much higher level of trust, transparency, and security. There are also automated tools for informed trading decisions and the opportunity for novice traders to copy the most experienced traders through the Copy Trader infrastructure.

The Pullix token is used for governance and is the native utility token. Investors are eligible for fixed income from earnings on the platform and can provide liquidity for automated market makers (AMM) on the platform. This operates through its liquidity provision system. During Stage 7 of its presale, it trades at $0.10 and has sold over 80 million tokens. In fact, nearly $5 million has been raised, showcasing a massive level of interest in this altcoin.

Summary

It’s clear that Injective and Litecoin are currently struggling to reach new heights, and as a result, many traders are looking for alternatives through which they can diversify their holdings. The Pullix DeFi project has stood out with its vast ecosystem and earning opportunities, and these aspects have made it an appealing high-growth opportunity.

For more information regarding Pullix’s presale see links: Visit Pullix, Join The Pullix Communities.

Disclaimer: Coinspeaker is not responsible for the trustworthiness, quality, accuracy of any materials on this page. We recommend you conduct research on your own before taking any decisions related to the products/companies presented in this article. Coinspeaker is not liable for any loss that can be caused due to your use of any services or goods presented in the press release.